Phreesia EBITDA 2019-2025 | PHR

Phreesia ebitda from 2019 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Phreesia Annual EBITDA
(Millions of US $)
2025 $-28
2024 $-106
2023 $-149
2022 $-93
2021 $-7
2020 $1
2019 $5
2018 $-3
Phreesia Quarterly EBITDA
(Millions of US $)
2025-04-30 $4
2025-01-31 $-1
2024-10-31 $-5
2024-07-31 $-10
2024-04-30 $-12
2024-01-31 $-21
2023-10-31 $-24
2023-07-31 $-30
2023-04-30 $-30
2023-01-31 $-32
2022-10-31 $-33
2022-07-31 $-40
2022-04-30 $-44
2022-01-31 $-40
2021-10-31 $-30
2021-07-31 $-18
2021-04-30 $-5
2021-01-31 $-4
2020-10-31 $-2
2020-07-31 $-1
2020-04-30 $-1
2020-01-31 $0
2019-10-31 $2
2019-07-31 $0
2019-04-30 $0
2019-01-31
2018-10-31 $1
2018-07-31 $-1
2018-01-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.604B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.442B 59.08
Hims & Hers Health (HIMS) United States $14.813B 153.91
Doximity (DOCS) United States $11.035B 51.09
Tempus AI (TEM) United States $9.797B 0.00
IRhythm Technologies (IRTC) United States $4.475B 0.00
Inspire Medical Systems (INSP) United States $3.673B 57.39
Hinge Health (HNGE) United States $3.507B 0.00
Privia Health (PRVA) United States $2.380B 162.67
10x Genomics (TXG) United States $1.656B 0.00
Enovis (ENOV) United States $1.531B 8.53
Azenta (AZTA) United States $1.497B 69.57
Schrodinger (SDGR) United States $1.492B 0.00
Clover Health Investments (CLOV) United States $1.471B 0.00
Omnicell (OMCL) United States $1.453B 27.44
Evolent Health (EVH) United States $1.180B 100.50
Claritev (CTEV) United States $0.655B 0.00
Veradigm (MDRX) United States $0.531B 0.00
Fulgent Genetics (FLGT) United States $0.523B 0.00
Standard BioTools (LAB) United States $0.505B 0.00
Butterfly Network (BFLY) United States $0.423B 0.00
Talkspace (TALK) United States $0.407B 121.50
TruBridge (TBRG) United States $0.313B 694.00
Outset Medical (OM) United States $0.285B 0.00
Nyxoah SA (NYXH) Belgium $0.254B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
Zepp Health (ZEPP) Netherlands $0.195B 0.00
CapsoVision (CV) United States $0.179B 0.00
KORU Medical Systems (KRMD) United States $0.160B 0.00
American Well (AMWL) United States $0.115B 0.00
EUDA Health Holdings (EUDA) Singapore $0.114B 0.00
MDxHealth SA (MDXH) Belgium $0.113B 0.00
CareCloud (CCLD) United States $0.101B 3.84
ImmunoPrecise Antibodies (IPA) Canada $0.077B 0.00
Pulmonx (LUNG) United States $0.074B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.072B 0.00
111 (YI) China $0.059B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.038B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Healthcare Triangle (HCTI) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
PROFUSA (PFSA) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00